Breaking News Instant updates and real-time market news.

APHA

Aphria

$6.44

-0.12 (-1.83%)

, BZUN

Baozun

$50.05

0.05 (0.10%)

08:45
07/19/19
07/19
08:45
07/19/19
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Aphria (APHA) 50.37% +1.92, Baozun (BZUN) 6.70% +0.30, Canopy Growth (CGC) 35.07% +0.30, Uber (UBER) 1.60% +0.20, PetMed Express (PETS) 7.13% +0.06, Luckin Coffee (LK) 9.78% +0.03, Elastic NV (ESTC) 0.62% +0.02, Teck Resources (TECK) 0.30% +0.01, Gold Bear 3x (DUST) 13.72% +0.01, and Dillard's (DDS) 30.67% +0.01.

APHA

Aphria

$6.44

-0.12 (-1.83%)

BZUN

Baozun

$50.05

0.05 (0.10%)

CGC

Canopy Growth

$35.79

-0.78 (-2.13%)

UBER

Uber

$43.70

0.08 (0.18%)

PETS

PetMed Express

$16.27

-0.68 (-4.01%)

LK

Luckin Coffee

$19.96

0.46 (2.36%)

ESTC

Elastic

$97.78

1.82 (1.90%)

TECK

Teck Resources

$22.01

-0.21 (-0.95%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

$8.06

-1.2 (-12.96%)

DDS

Dillard's

$64.05

-0.3 (-0.47%)

  • 22

    Jul

  • 25

    Jul

  • 26

    Jul

  • 01

    Aug

  • 08

    Aug

APHA Aphria
$6.44

-0.12 (-1.83%)

05/24/19
JEFF
05/24/19
INITIATION
JEFF
Buy
Jefferies starts Aphria at Buy, says valuation 'not reflective of reality'
Jefferies analyst Owen Bennett initiated coverage of Aphria (APHA) with a Buy rating and C$15 price target. The stock closed yesterday down 33c to $6.41. The analyst says the company scores highly on his "strategic scorecard," or third overall behind only Canopy Growth (CGC) and Aurora Cannabis (ACB). Despite a "strong global outlook," Aphria's valuation is the cheapest across the space, with allegations around inflated assets/insider deals weighing on the shares, Bennett tells investors in a research note. The analyst expects a "significant re-rating" in the shares with "these issues now seemingly cleared up." He points out that the company's questionable relationships have been severed and a special committee review found assets had not been falsely inflated. Bennett believes Aphria continues to execute and that its valuation is "not reflective of reality."
04/16/19
VERF
04/16/19
NO CHANGE
Target $8
VERF
Sell
Use Aphria results as guide and short Tilray shares, says Vertical Group
Vertical Group analyst Gordon Johnson tells investors to use Aphria's (APHA) fiscal Q3 results as a guide and build a short position in Tilray (TLRY). The analyst last week initiated coverage of Tilray with a Sell rating and $8 year-end price target. Despite expectations for growth in Canadian sales due to the growth expectations for the recreational cannabis market, Aphria's kilograms sold fell 22.7% quarter-over-quarter in the quarter reported yesterday, Johnson tells investors in an email to clients. The analyst maintains his negative bias on Tilray following Aphia's results. Shares of Tilray are up 54c to $49.78 in early trading.
05/24/19
05/24/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zoom Video (ZM) initiated with a Perform at Oppenheimer. 2. CannTrust (CTST) initiated with a Buy at BofA/Merrill. 3. Inseego (INSG) initiated with an Outperform at Cowen. 4. Falcon Minerals (FLMN) initiated with an Outperform at Baird. 5. Aphria (APHA) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/10/19
PIPR
06/10/19
NO CHANGE
PIPR
Cannabis regulation could become top 2020 election issue, says Piper Jaffray
After Washington D.C. lobbyist Michael Esposito, who also works closely with President Trump's administration, spoke at his firm's conference, Piper Jaffray analyst Michael Lavery believes cannabis regulation could become a top 2020 election issue. By supporting cannabis, Trump may be able to incrementally broaden his appeal with swing voters without alienating his base, Esposito tells investors in a research note. Though Trump has indicated his willingness to support the STATES Act, his enthusiasm could depend on whether or not Elizabeth Warren, author of the bill, is his opponent, adds the analyst in a note titled "Handicapping US Legalization Outlook: Politics Are Complicated." And while Senate Majority Leader Mitch McConnell is a roadblock for legislation in the Senate, Trump could use executive orders between now and the election to show support for the industry, potentially relating to cannabis banking or medical research, says Lavery. The analyst has Overweight ratings on both Canopy Growth (CGC) and Tilray (TLRY). Other names in the space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), MediPharm Labs (MLCPF) and Zynerba (ZYNE).
BZUN Baozun
$50.05

0.05 (0.10%)

10/11/18
THCP
10/11/18
NO CHANGE
THCP
Baozun likely to be conservative with guidance, says TH Data Capital
TH Data Capital analyst Tian Hou believes Baozun added 10 GMV partners and 8 brand partners in Q3 and expects the company's net revenue growth to be in line with the consensus view and largely inline with the mid-point of company view. Given the slower pace of Chinese economic growth, Hou believes Baozun, along with many other Chinese companies, will take a conservative approach toward its guidance, he tells investors.
10/11/18
LYON
10/11/18
UPGRADE
LYON
Buy
Baozun upgraded to Buy from Outperform at CLSA
CLSA analyst Man Ho Lam upgraded Baozun to Buy ahead of Q3 results citing the recent pullback in shares.
CGC Canopy Growth
$35.79

-0.78 (-2.13%)

07/17/19
LTCO
07/17/19
INITIATION
Target $50
LTCO
Buy
Canopy Growth initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Glenn Mattson started Canopy Growth with a Buy rating and $50 price target. Within the cannabis space, the analyst favors Canadian companies who are focused on long-term value creation and gaining market share as well as those with a well-defined plan for potentially entering the U.S. market. He initiated coverage on the cannabis space with a "bullish long-term outlook." Despite slower than expected growth in the most recently reported quarter, Canopy Growth remains one of the best ways to play the cannabis space, Mattson tells investors in a research note. Given its "significant" balance sheet, Canopy has the greatest flexibility to go after new growth opportunities as they emerge, says the analyst.
07/17/19
LTCO
07/17/19
INITIATION
Target $18
LTCO
Buy
Acreage Holdings initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Glenn Mattson started Acreage Holdings (ACRGF) with a Buy rating and $18 price target. Within the cannabis space, the analyst favors Canadian companies who are focused on long-term value creation and gaining market share as well as those with a well-defined plan for potentially entering the U.S. market. He initiated coverage on the cannabis space with a "bullish long-term outlook." Acreage has a "solid position" in the most attractive areas of the U.S., Mattson tells investors in a research note. Further, the company trades at a "significant discount" to the implied conversion from the proposed Canopy Growth (CGC) transaction, which will execute upon federal legalization of cannabis in the U.S., the analyst ads.
07/08/19
PIPR
07/08/19
NO CHANGE
Target $54
PIPR
Overweight
Canopy Growth price target lowered to $54 from $57 at Piper Jaffray
Piper Jaffray analyst Michael Lavery lowered his price target for Canopy Growth to $54 from $57 citing the company's slower than expected retail rollout. The analyst, however, reiterates an Overweight rating on the shares. Further retail openings in Canada, especially Ontario, will drive Canopy's market growth, but they continue to progress at a very slow pace, Lavery tells investors in a research note. California has $200M in monthly sales while Canada has only $60M, despite similar population sizes, the analyst points out. Further, Lavery believes the termination of Co-CEO Bruce Linton "likely signals more discipline to come." A successor could bring a more disciplined approach that investors are likely to welcome, contends the analyst.
07/05/19
07/05/19
DOWNGRADE

Canopy Growth downgraded to Neutral from Buy at Bryan Garnier
Bryan Garnier analyst Nikolaas Faes yesterday downgraded Canopy Growth to Neutral from Buy and lowered his price target for the shares to C$60 from C$85.
UBER Uber
$43.70

0.08 (0.18%)

07/11/19
NEED
07/11/19
NO CHANGE
Target $52
NEED
Buy
Uber value creation positioning optimal, says Needham
Needham analyst Brad Erickson kept his Buy rating and $52 price target on Uber, saying his long-term bull case scenario has the stock trading to $130. The analyst contends that "excess supply" is critical to the company driving a "transformational change in transportation", which the company is pursuing with its current $3B EBITDA headwind. Erickson is also positive on Uber's "optimal" positioning for value creation after discussing the potential for driving autonomy with the head of transportation of one of the mid-size cities in the U.S.
07/10/19
JEFF
07/10/19
NO CHANGE
Target $90
JEFF
Buy
Jefferies sees Lyft recovering with shares 14% below IPO price
Lyft (LYFT) is trading 14% below its initial public offering price of $72 per share, Jefferies analyst Brent Thill tells investors in a research note. The analyst expects the stock to recover as the company "executes and misconceptions clear." For the stock to work, Lyft must overcome concerns that its growth will be capped as a number two player behind Uber (UBER) and disprove bears who claim the company will never make money, contends Thill. He believes that doing so will expand the stock's valuation multiple. The analyst continues to like Lyft for its "highly focused approach to solving the problems of personal transportation." Thill keeps a Buy rating on the shares with a $90 price target. The stock closed Tuesday up $2.04 to $61.83.
07/15/19
NEED
07/15/19
NO CHANGE
Target $52
NEED
Buy
Uber interest in Postmates may be at lower price, says Needham
Needham analyst Brad Erickson writes that his recent channel checks with Chicago restaurants suggest that Uber (UBER) may be gaining some market share on the leader GrubHub (GRUB). The analyst also believes that the "fickleness" of customers would require some consolidation, but contends that Uber's speculated interest in acquiring Postmates is likely at a lower price than indicated in the recent Recode report. Erickson is keeping his Buy rating on Uber with a price target of $52 and a bull case of $130.
07/11/19
MSCO
07/11/19
NO CHANGE
Target $305
MSCO
Overweight
Domino's reasonably insulated from 3rd party delivery risk, says Morgan Stanley
Morgan Stanley analyst John Glass said he is not dismissive of the sales risk posed to Domino's Pizza (DPZ) by third-party food delivery aggregators, but his county-by-county analysis of its U.S. stores overlapped against markets where third party delivery is or is expected to be most concentrated leads him to believe that the risk has a "reasonable boundary" of a 1%-2% impact on same-store sales. Using the same data, he concluded that Domino's still has an opportunity to grow its current U.S. store base of about 5,900 to at least 8,000-9,000 units over time, said Glass, who keeps an Overweight rating on Domino's shares with a $305 price target. Publicly traded companies that operate third-party food delivery services include GrubHub (GRUB) and Uber (UBER).
PETS PetMed Express
$16.27

-0.68 (-4.01%)

07/23/18
CHLM
07/23/18
NO CHANGE
CHLM
PetMed Express price target lowered to $29 from $32 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich kept a Sell rating on PetMed Express and lowered his price target on shares to $29 from $32. Ellich said gross margin was "adversely impacted" by greater pricing discounts due to competition from smaller online retailers. The analyst also noted that Q1 results were mixed, with an EPS miss and "new customer additions were somewhat underwhelming."
01/23/19
CHLM
01/23/19
NO CHANGE
Target $18
CHLM
Sell
PetMed Express price target lowered to $18 from $25 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich lowered his price target for PetMed Express to $18 from $25 after Q3 results missed estimates across the board due to increased competition that continues to affect the company as new customer acquisition costs were higher than expected while new customers added were the lowest since the analyst began tracking the metric in FY10. Ellich reiterates a Sell rating on the stock.
10/22/18
CHLM
10/22/18
NO CHANGE
CHLM
Sell
PetMed Express new competition negatively impacts, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich reiterated his Sell rating on PetMed Express and lowered his price target to $25 from $29 following the Q2 report. Ellich said PetMed beat, but increased competition negatively impact new customer sales and increased customer acquisition costs.
07/15/19
CHLM
07/15/19
NO CHANGE
CHLM
Sell
PetMed CEO amendment hints at exploration of alternatives, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich noted that PetMed Express (PETS) filed an 8K after the close on Friday to disclose that it amended CEO Mendo Akdag's employment agreement to add the language "for Good Reason" to the "Change in Control" section. He reads this change as a hint that an exploration of strategic alternatives could be upcoming, though he doesn't think there is anything imminent in the works. The analyst, who suspects there is further downside to Street estimates for PetMed given increased competition from Chewy (CHWY), Walmart (WMT), Petco and other online retailers, keeps a Sell rating on PetMed shares.
LK Luckin Coffee
$19.96

0.46 (2.36%)

06/12/19
CICC
06/12/19
INITIATION
Target $22.3
CICC
Buy
Luckin Coffee initiated with a Buy at CICC
CICC started Luckin Coffee with a Buy rating and $22.30 price target.
06/12/19
SBSH
06/12/19
NO CHANGE
SBSH
Citi survey shows little impact to Starbucks in China from trade war
Citi analyst Gregory Badishkanian says his survey of over 300 Chinese coffee market consumers indicated the consumers are "generally indifferent" about purchasing American goods versus 12 months ago. This suggests relatively little impact to Starbucks (SBUX) from the recent geopolitical disputes, Badishkanian tells investors in a research note. Further, the survey shows Starbucks is leading on taste while competitors are leading on price, adds the analyst.
06/11/19
FBCO
06/11/19
INITIATION
Target $24
FBCO
Outperform
Luckin Coffee initiated with an Outperform at Credit Suisse
Credit Suisse initiated Luckin Coffee with an Outperform rating and $24 price target.
06/11/19
MSCO
06/11/19
INITIATION
Target $21
MSCO
Equal Weight
Luckin Coffee initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Lillian Lou initiated Luckin Coffee with an Equal Weight rating and $21 price target. While she thinks Luckin's disruptive business model and competitive prices should allow it to grow sales by 30x in 2018-21, Lou thinks the stock's valuation looks fair at current levels. She also sees "a relatively high level of execution risk" and limited earnings visibility in the near-term.
ESTC Elastic
$97.78

1.82 (1.90%)

06/10/19
FBNS
06/10/19
NO CHANGE
Target $100
FBNS
Outperform
Elastic price target raised to $100 from $95 at FBN Securities
FBN Securities analyst Shebly Seyrafi raised his price target for Elastic to $100 from $95 citing the company's above-consensus fiscal Q4 results. The shares were weak post-earnings due to the company's announced intention to acquire endpoint security company Endgame for $234M in stock, but the deal will improve Elastic's position in security, Seyrafi tells investors in a research note. He reiterates an Outperform rating on the shares.
06/06/19
BOFA
06/06/19
NO CHANGE
Target $135
BOFA
Buy
Elastic price target raised to $135 from $115 at BofA/Merrill
BofA/Merrill analyst Kash Rangan reiterated a Buy rating on Elastic N.V. and raised his price target to $135 from $115, saying the company printed a "solid" quarter with revenues coming in ahead of the Street, with operating margin also beating estimates. In a research note to investors, the analyst notes that Elastic's fiscal 2020 revenue guidance of +47% y/y came in closer to his "high growth" scenario and says he sees many growth vectors ahead for the stock, saying he thinks Elastic is uniquely positioned to become one of the few small software franchises that can scale to $1B in revenues over the next 4-5 years.
06/06/19
JEFF
06/06/19
NO CHANGE
Target $90
JEFF
Hold
Elastic reported 'strong' Q4, but valuation still 'rich,' says Jefferies
Jefferies analyst John DiFucci says Elastic reported "strong" fiscal Q4 results across all metrics. While revenue guide was slightly above the Street for fiscal Q1 and was "very strong" for the year, earnings forecasts were "materially" below consensus, as the company "doubles down on R&D and invests in global sales," DiFucci tells investors in a research note. The analyst, who continues to believe Elastic "can be a much bigger entity" in five years, keeps a Hold rating on the name with a $90 price target citing the current "rich" valuation.
06/20/19
LEHM
06/20/19
NO CHANGE
Target $108
LEHM
Overweight
Elastic bear thesis around AWS competition overblown, says Barclays
Barclays analyst Raimo Lenschow believes the bear thesis for Elastic (ESTC) around competition from Amazon Web Services' (AMZN) Open Distro is overblown. The features released by AWS will likely help it convert a share of the millions of free users onto its platform, but Elastic focuses on large scale deployments, Lenschow tells investors in a research note. This is where Elastic will continue to generate the vast majority of its sales growth, says the analyst. He believes the company's runway of growth with enterprises is unaffected by Open Distro and encourages long-term investors to buy into the recent share weakness caused by the lockup expiry. Lenschow reiterates an Overweight rating on Elastic with a $108 price target.
TECK Teck Resources
$22.01

-0.21 (-0.95%)

05/24/19
MKMP
05/24/19
NO CHANGE
Target $38
MKMP
Buy
Warrior Met Coal price target raised to $38 from $33 at MKM Partners
MKM Partners analyst Daniel Scott raised his price target on Warrior Met Coal (HCC) to $38 and kept his Buy rating as part of his broader research note titled "Coking Coal Staying Strong." The analyst maintains his multi-quarter view that the market for coking coal is "resilient" and demand is experiencing "continued strength" amid slow supply response from producers in Australia, U.S., and Canada. Scott adds that the $200 per metric ton price level is close to becoming a "new normal", while noting that valuation on the coking coal stocks is still "well below mid-cycle ranges". As part of his research note, the analyst also raises his FY19 and FY20 revenue and EBITDA forecasts for Peabody Energy (BTU) and Teck Resources (TECK).
07/10/19
MACQ
07/10/19
INITIATION
MACQ
Neutral
Teck Resources initiated with a Neutral at Macquarie
Macquarie analyst David Lipschitz initiated Teck Resources with a Neutral rating.
04/04/19
MKMP
04/04/19
NO CHANGE
Target $26
MKMP
Buy
Teck Resources' coking coal operations performing well, says MKM Partners
MKM Partners analyst Daniel Scott kept his Buy rating and $26 price target on Teck Resources after its Investor Day presentation. The analyst says the company's coking coal operations - his area of focus - is "performing well in a continued strong commodity environment" and offers the "best reserve life" in his coverage. Scott adds that coking coal assets will be Teck's "free cash flow generating machines" over the intermediate to long term, supporting the company's already "strong financial position" with CAD6.6B of liquidity an no significant maturity until 2024.
04/09/19
LEHM
04/09/19
NO CHANGE
LEHM
Barclays still positive on Metals and Mining, downgrades three on valuation
Barclays analyst Matthew Murphy remains positive on shares in the North America Metals and Mining space. The potential for higher recession probabilities could still drive demand for "safe assets," Murphy tells investors in a research note. Further, copper should benefit from a sequential acceleration in China during Q2, says the analyst. He sees several names with "significant upside" and "catalyst potential" including Teck Resources (TECK), Barrick Gold (GOLD), and Newmont Mining (NEM) and Goldcorp (GG). To reflect valuation, Murphy upgraded OceanaGold (OCANF) to Overweight from Equal Weight and downgraded to Equal Weight from Overweight shares of Agnico Eagle (AEM), Franco-Nevada (FNV) and Wheaton Precious Metals (WPM).
DUST Direxion Daily Gold Miners Bear 3X ETF
$8.06

-1.2 (-12.96%)

DDS Dillard's
$64.05

-0.3 (-0.47%)

05/16/19
DBAB
05/16/19
NO CHANGE
Target $53
DBAB
Sell
Deutsche sees risk ahead for Dillard's, lowers price target to $53
While Dillard's Q1 earnings came in ahead of expectations, the beat was driven by lower expenses and asset sales, Deutsche Bank analyst Paul Trussell tells investors in a research note. The analyst says the Q1 report furthers his concerns around ongoing margin declines, "especially as the company cycles tougher comp compares this year." He sees more risk ahead and reiterates a Sell rating on Dillard's while lowering his price target for the shares to $53 from $56.
05/16/19
WEDB
05/16/19
NO CHANGE
Target $54
WEDB
Underperform
Dillard's price target lowered to $54 from $65 at Wedbush
Wedbush analyst Jen Redding lowered her price target for Dillard's to $54 from $65 after Q1 results "disappointed," noting that the management's silence left him particularly cautious. The analyst reiterates an Underperform rating on the shares.
07/11/19
07/11/19
UPGRADE
Target $62

Neutral
Dillard's upgraded to Neutral at Wedbush as promotional data shows stabilization
As previously reported, Wedbush analyst Jen Redding upgraded Dillard's to Neutral from Underperform as promotional levels stabilize, according to Search Trends and her Promo Tracker, and valuation strikes her as reasonable. The analyst notes that more recent promotional data shows stabilization in markdown trends, as promotions over the July 4th holiday approximated depth and duration levels year over year. As promotional levels stabilize, search trends show upward momentum in demand by about 740 bps in June from May, with early July data still stronger, coupled with an uptick in recent Form 4 insider purchasing, she adds. Redding also raised her price target on the shares to $62 from $54.
07/11/19
WEDB
07/11/19
UPGRADE
WEDB
Neutral
Dillard's upgraded to Neutral from Underperform at Wedbush

TODAY'S FREE FLY STORIES

CBS

CBS

$43.83

0.5 (1.15%)

, VIA

Viacom

$27.27

-0.4 (-1.45%)

08:03
08/17/19
08/17
08:03
08/17/19
08:03
Periodicals
Viacom-CBS merger got panned by investors, Barron's says »

CBS (CBS) and Viacom…

CBS

CBS

$43.83

0.5 (1.15%)

VIA

Viacom

$27.27

-0.4 (-1.45%)

VIAB

Viacom

$26.02

0.09 (0.35%)

AAPL

Apple

$206.44

4.71 (2.33%)

DIS

Disney

$135.19

1.79 (1.34%)

T

AT&T

$34.98

0.64 (1.86%)

CMCSA

Comcast

$43.17

0.82 (1.94%)

CMCSK

Comcast

$0.00

(0.00%)

NFLX

Netflix

$302.74

6.81 (2.30%)

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 23

    Sep

  • 23

    Oct

  • 27

    Oct

MYGN

Myriad Genetics

$25.36

2.14 (9.22%)

07:57
08/17/19
08/17
07:57
08/17/19
07:57
Periodicals
Myriad Genetics stock might have an FDA issue, Barron's says »

Myriad Genetics plunged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSCO

Cisco

$46.96

0.73 (1.58%)

, NTAP

NetApp

$46.75

0.33 (0.71%)

07:50
08/17/19
08/17
07:50
08/17/19
07:50
Periodicals
Trade war hitting tech stocks, Barron's says »

Cisco (CSCO) plunged 9% a…

CSCO

Cisco

$46.96

0.73 (1.58%)

NTAP

NetApp

$46.75

0.33 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 10

    Oct

  • 13

    Nov

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

, RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

07:47
08/17/19
08/17
07:47
08/17/19
07:47
Periodicals
Investors should not abandon oil, gas stocks, Barron's says »

Energy stocks have rarely…

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

BP

BP

$36.27

0.22 (0.61%)

XOM

Exxon Mobil

$68.30

1.06 (1.58%)

CVX

Chevron

$115.79

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

TGT

Target

$84.20

1.67 (2.02%)

, WMT

Walmart

$112.99

0.32 (0.28%)

07:40
08/17/19
08/17
07:40
08/17/19
07:40
Periodicals
Grocery Outlet thriving as rivals struggle, Barron's says »

While Dow was down 800…

TGT

Target

$84.20

1.67 (2.02%)

WMT

Walmart

$112.99

0.32 (0.28%)

GO

Grocery Outlet

$46.55

2.81 (6.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

AEO

American Eagle

$15.40

0.63 (4.27%)

07:33
08/17/19
08/17
07:33
08/17/19
07:33
Periodicals
American Eagle to soar despite trade war, Barron's says »

American Eagle's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 25

    Sep

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

, MTCH

Match Group

$84.53

2.08 (2.52%)

07:27
08/17/19
08/17
07:27
08/17/19
07:27
Periodicals
Dating business might be IAC's best asset, greatest challenge, Barron's says »

IAC (IAC) has rallied 34%…

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

MTCH

Match Group

$84.53

2.08 (2.52%)

IAC

IAC

$249.17

4.21 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 10

    Sep

  • 10

    Oct

AAPL

Apple

$206.44

4.71 (2.33%)

, HAS

Hasbro

$114.29

1.13 (1.00%)

07:13
08/17/19
08/17
07:13
08/17/19
07:13
On The Fly
Week in review How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$206.44

4.71 (2.33%)

HAS

Hasbro

$114.29

1.13 (1.00%)

MAT

Mattel

$10.74

(0.00%)

AGR

Avangrid

$49.29

0.37 (0.76%)

JPM

JPMorgan

$107.73

2.52 (2.40%)

BAC

Bank of America

$27.04

0.79 (3.01%)

C

Citi

$63.46

2.13 (3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 09

    Sep

  • 02

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 27

    Oct

NCLH

Norwegian Cruise Line

$50.48

1.38 (2.81%)

18:04
08/16/19
08/16
18:04
08/16/19
18:04
Hot Stocks
Norwegian Cruise Line CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RM

Regional Management

$27.12

0.14 (0.52%)

18:01
08/16/19
08/16
18:01
08/16/19
18:01
Hot Stocks
Regional Management CFO buys 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

RTN

Raytheon

$178.10

-0.42 (-0.24%)

17:59
08/16/19
08/16
17:59
08/16/19
17:59
Hot Stocks
Raytheon awarded $199.59M Navy contract for MK 15 CIWS »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$19.94

0.16 (0.81%)

17:57
08/16/19
08/16
17:57
08/16/19
17:57
Hot Stocks
Breaking Hot Stocks news story on Wendy's »

Trian Fund lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BRY

Berry Petroleum

$8.59

0.39 (4.76%)

17:54
08/16/19
08/16
17:54
08/16/19
17:54
Syndicate
Breaking Syndicate news story on Berry Petroleum »

Berry Petroleum files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSWI

CSW Industrials

$70.20

1.92 (2.81%)

17:52
08/16/19
08/16
17:52
08/16/19
17:52
Hot Stocks
CSW Industrials CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$3.03

0.135 (4.66%)

17:49
08/16/19
08/16
17:49
08/16/19
17:49
Hot Stocks
Oasis Petroleum CEO buys 30K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EE

El Paso Electric

$66.41

0.005 (0.01%)

17:45
08/16/19
08/16
17:45
08/16/19
17:45
Hot Stocks
El Paso Electric director Wertheimer sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$165.07

2.81 (1.73%)

17:42
08/16/19
08/16
17:42
08/16/19
17:42
Hot Stocks
Honeywell CEO sells 7.1K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.08

0.01 (0.93%)

17:37
08/16/19
08/16
17:37
08/16/19
17:37
Earnings
Moleculin Biotech reports Q2 EPS (3c), two estimates (10c) »

CFO Jonathan Foster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$0.13

0.0046 (3.59%)

17:35
08/16/19
08/16
17:35
08/16/19
17:35
Syndicate
Breaking Syndicate news story on Viveve »

Viveve files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGO

Perrigo

$46.21

0.535 (1.17%)

17:30
08/16/19
08/16
17:30
08/16/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Perrigo »

Starboard lowers Perrigo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UAL

United Continental

$82.96

1.36 (1.67%)

17:28
08/16/19
08/16
17:28
08/16/19
17:28
Hot Stocks
United Continental director Shapiro buys 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 23

    Sep

MBIO

Mustang Bio

$3.88

0.19 (5.15%)

17:26
08/16/19
08/16
17:26
08/16/19
17:26
Syndicate
Breaking Syndicate news story on Mustang Bio »

Mustang Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

BCLI

BrainStorm

$3.63

0.055 (1.54%)

17:24
08/16/19
08/16
17:24
08/16/19
17:24
Syndicate
Breaking Syndicate news story on BrainStorm »

BrainStorm files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLK

Westlake Chemical

$61.27

0.66 (1.09%)

17:15
08/16/19
08/16
17:15
08/16/19
17:15
Hot Stocks
Westlake Chemical raises quarterly dividend by 5% to 26.25c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIG

GigCapital

$10.30

(0.00%)

17:10
08/16/19
08/16
17:10
08/16/19
17:10
Hot Stocks
GigCapital receives noncompliance notice from NYSE »

GigCapital announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.